Can This Stock Double Again in 2026? [Yahoo! Finance]
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
Company Research
Source: Yahoo! Finance
The medicine could join the fast-growing weight loss market, but it will face plenty of competition. The clinical-stage biotech could see its shares plummet should there be any clinical setback. 10 stocks we like better than Structure Therapeutics › Structure Therapeutics (NASDAQ: GPCR) ended 2025 on a strong note. Shares of the clinical-stage biotech soared in December after it reported strong mid-stage data for its leading pipeline candidate, an investigational weight loss medicine called aleniglipron. If Structure Therapeutics can make more progress toward entering the fast-growing anti-obesity market this year, we could see the company carrying the momentum it had last year through 2026. But can the stock really deliver the kinds of returns it did last year? And is it worth investing in for those focused on the long game? Let's find out. Aleniglipron is a once-daily oral GLP-1 candidate. In a 36-week phase 2b study , the medicine posted a competitive placebo-adjusted me
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Assessing Structure Therapeutics (GPCR) Valuation After Sharp Swings And A Strong 1 Year Return [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics (GPCR) had its price target lowered by Citizens Jmp from $120.00 to $113.00. They now have a "market outperform" rating on the stock.MarketBeat
- Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent HighlightsGlobeNewswire
GPCR
Sec Filings
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- GPCR's page on the SEC website